Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rummukainen

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
The Lancet. Infectious Diseases|May 25, 2007
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?Jane Zuckerman, Jan van Hattum, Mary Cafferkey, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancerAnna Sutela, Ritva Vanninen, Mazen Sudah, et al.
Bone|February 14, 2021
Early B-cell Factor1 (Ebf1) promotes early osteoblast differentiation but suppresses osteoblast functionVappu Nieminen-Pihala, Kati Tarkkonen, Julius Laine, et al.
Pediatric Research|March 29, 2012
Fatal neonatal lactic acidosis caused by a novel de novo mitochondrial G7453A tRNA-Serine ((UCN)) mutationAlexandra Götz, Pirjo Isohanni, Brita Liljeström, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Expression of HER2 and its association with AP-2 in breast cancerJ Pellikainen, A Naukkarinen, K Ropponen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2022
Distinctive effects of SGLT2 inhibitors on angiogenesis in zebrafish embryosRoope Huttunen, Annele Sainio, Anja Hjelt, et al.
Archives of Dermatological Research|January 29, 2011
Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitroNicolae-Costin Diaconu, Jaana Rummukainen, Anita Naukkarinen, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological FeaturesLiina Kuuluvainen, Minna Pöyhönen, Petra Pasanen, et al.
BMC Cancer|February 9, 2008
Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysisNicolae-Costin Diaconu, Jaana Rummukainen, Mikko Mättö, et al.
Neuropathology and Applied Neurobiology|June 24, 2011
Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literatureV Leinonen, A M Koivisto, S Savolainen, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Infectious Diseases|May 25, 2007
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?Jane Zuckerman, Jan van Hattum, Mary Cafferkey, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancerAnna Sutela, Ritva Vanninen, Mazen Sudah, et al.
Bone|February 14, 2021
Early B-cell Factor1 (Ebf1) promotes early osteoblast differentiation but suppresses osteoblast functionVappu Nieminen-Pihala, Kati Tarkkonen, Julius Laine, et al.
Pediatric Research|March 29, 2012
Fatal neonatal lactic acidosis caused by a novel de novo mitochondrial G7453A tRNA-Serine ((UCN)) mutationAlexandra Götz, Pirjo Isohanni, Brita Liljeström, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Expression of HER2 and its association with AP-2 in breast cancerJ Pellikainen, A Naukkarinen, K Ropponen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2022
Distinctive effects of SGLT2 inhibitors on angiogenesis in zebrafish embryosRoope Huttunen, Annele Sainio, Anja Hjelt, et al.
Archives of Dermatological Research|January 29, 2011
Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitroNicolae-Costin Diaconu, Jaana Rummukainen, Anita Naukkarinen, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological FeaturesLiina Kuuluvainen, Minna Pöyhönen, Petra Pasanen, et al.
BMC Cancer|February 9, 2008
Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysisNicolae-Costin Diaconu, Jaana Rummukainen, Mikko Mättö, et al.
Neuropathology and Applied Neurobiology|June 24, 2011
Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literatureV Leinonen, A M Koivisto, S Savolainen, et al.
Pageof 9